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INTRODUCTION:  Multicentric  Reticulohistiocytosis  (MRH)  is  a  rare  non-Langerhans  cell  histiocytosis  char-
acterised  by  destructive  polyarthritis  and  violaceous  skin  papules.
PRESENTATION OF  CASE:  In 2010,  a 70-year-old  woman  with  Palindromic  Rheumatism  was diagnosed  with
MRH.  Within  a few  months,  she  developed  ankylosis  of  the  small  joints  of  both  hands  which  resulted  in
severe  ﬁxed  ﬂexion  deformities  of  the ﬁngers  and  thumbs.  The  joint  disease  failed  to  respond  to  medical
therapies  and  the  palmar  skin  of  her  left  hand  was  becoming  increasingly  macerated.  Therefore,  she
elected  to undergo  arthrodesis  of  the  metacarpophalangeal  joints  to allow  hand  hygiene.
DISCUSSION: To-date,  this  is  the  ﬁrst  report  of  a surgical  intervention  for this  rare condition  and represents
a  novel  avenue  of  potential  therapy.  Medical  therapies  for MRH  are  usually  ineffective  in preventing  the
debilitating  small  joint  disease  which  often  develops  and  there  is  on-going  research  into  newer  agents
and  alternative  surgical  techniques.
CONCLUSION: Once  medical  therapies  are  exhausted,  clinicians  should  consider  the  input  of  Hand  Sur-
geons  in managing  the  inevitable  and  mutilating  joint  disease  of  this  rare  condition.rthritis
nkylosis
rthrodesis
usion
and
urgery
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. Case history
In January 2010, a 70-year-old woman presented to the
heumatology clinic with ﬂexion deformities affecting both hands.
er medical history included burnt-out Palindromic Rheumatism
1984) with consistently negative Rheumatoid serology (RhF < 10),
aised ANA titres (2.5iU/mL) and no Extractable Nuclear Antigens.
he had a left total shoulder replacement (1988) and bilateral total
nee replacements (2002). Her medications were Sulphasalazine,
elodipine, Bisoprolol and Bendroﬂumethiazide. There was  no fam-
ly history or allergy of note.On examination, there were mild ﬂexion deformities of the
roximal interphalangeal joints (PIPJ) and distal interphalangeal
oints (DIPJ), affecting the ring and little ﬁngers. Initially, the right
Abbreviations: ANA, antinuclear antibodies; ENA, extractable nuclear anti-
ens;  PIPJ, proximal interphalangeal joint; DIPJ, distal interphalangeal joint; MCPJ,
etacarphophalangeal joint.
∗ Corresponding author at: Department of Medicine, James Paget University Hos-
ital NHS Foundation Trust, Gorleston, NR31 6LA, UK.
E-mail address: damodar.makkuni@jpaget.nhs.uk (D. Makkuni).
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Open access under CC BY-hand was more greatly affected. Flexion to make a ﬁst was achiev-
able. There was no signiﬁcant stiffness, pain or swelling within
any joints of the distal upper limb. There were no palpable palmar
fascial nodules or joint subluxations. The feet were not involved.
There were no other symptoms or signs of connective tissue dis-
ease. Radiographs of the hands and feet were unremarkable. With
an uncertain diagnosis, the opinion of a Hand Surgeon was sought.
Three months later, all digits of the right hand, and the left ring
and little ﬁngers were buried within the palm (Fig. 1); the MCPJs
were 90◦ the PIPJs 60◦ and the DIPJs 100◦ ﬂexed with minimal
passive extension possible. The left index and middle ﬁngers exhib-
ited less signiﬁcant ﬂexion deformities in a similar pattern. The
nails were well manicured and there was no palmar skin macera-
tion. Moreover, multiple ﬁrm and irregular pink-coloured papules
(1–4 mm)  had developed on the dorsum of the hands (Fig. 2) which
were not painful, itchy or apparent elsewhere. As before, no other
abnormalities were detected during the clinical examination of
other bodily systems.A  4 mm marginal punch biopsy of a skin lesion showed poorly
deﬁned dermal aggregates of histiocytes and multinucleated giant
cells, some with a wreath-like distribution of nuclei (Fig. 3). There
was associated perivascular lymphocytic inﬁltration and dermal
NC-ND license. 
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Fig. 1. An X-ray showing severe joint contractures of the left and right hands. No
new  erosions, peri-articular osteopenia, osteophytes or sclerotic change is clearly
seen. There is old erosive carpal arthritis attributable to Palindromic Rheumatism.
Fig. 2. A photograph of the right hand, showing the characteristic skin lesions of
MRH.
Fig. 3. A punch biopsy of a skin lesion on the left index ﬁnger showing histiocyte
and  multinucleated giant cell inﬁltration of the dermis (H&E stain, 200×).Fig. 4. A punch biopsy of a skin lesion on the index ﬁnger showing Periodic Acid-
Schiff  (PAS) staining positivity within the cytoplasm of some cells, with one giant
cell exhibiting a wreath-like distribution of nuclei.
ﬁbrosis. Periodic Acid Schiff (PAS) staining showed weak granu-
lar cytoplasmic positivity in the giant cells (Fig. 4). The histiocytic
component was negative for S100 and CD1a. No microorganisms
were present. These features alongside the clinical history indicated
Multicentric Reticulohistiocytosis. In order to exclude malignancy,
a full-body MRI  was ordered which showed a right-sided, 4 cm
spherical heterogeneous adrenal mass. The Endocrinologists later
determined this to be a non-functioning adenoma.
Intravenous zolendronate and methotrexate with steroids failed
to improve her digital ﬂexion deformities and consequently, the
ﬁngers were drawn into greater degrees of ﬂexion and her left pal-
mar skin became macerated. Physiotherapy did not improve her
symptoms. We  felt that given the degree of her deformities and
the nature of this akylosing disease that splints were unlikely to
confer any beneﬁt. Since conservative and medical therapies had
failed, we offered the patient palliative surgery. Given the degree of
deformity and lack of supporting soft tissue, her joints were unsuit-
able for arthroplasty. Considering the absence of literature on this
subject and the patient’s preference for minimal surgery, she was
counselled and consented for MCPJ arthrodesis. We  felt that this
approach was  most sensible in order to allow for hand hygiene
and if the outcome was satisfactory, then further fusion could be
considered. Therefore, under general anaesthetic and tourniquet,
the left MCPJs were approached with 4 longitudinal incisions. The
joint surfaces were adequately prepared and held in appropriate
degrees of ﬂexion with temporary K-wires, allowing ﬁnger manip-
ulation out of the palm and radial rotation of the index ﬁnger for
opposition. AO compact 2 mm hand plates were placed dorsally to
all 4 MCPJs.
Post-operative radiographs were satisfactory (Fig. 5). Following
6 weeks of ﬁrm nocturnal splint therapy, hand therapy was initi-
ated. At one year follow up her MCPJs remained appropriately fused
and she is able to hook grasp as well as achieve a weak key and ﬁne
pinch, which she believes is enough to improve her day-to-day life.
The joint disease has stabilised and the papular rash regressed with-
out adjuvant medical therapy. Orthopaedic and Rhuematological
follow-up continues 6 monthly alongside radiological surveillance
of her adrenal mass.
2.  DiscussionFirst described by Goltz and Laymon in 1954,1 MRH  is a rare non-
Langerhans histiocytosis characterised by destructive polyarthritis
and multiple skin lesions. To-date, there are few published reports
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aig. 5. A post-operative X-ray of the left hand and wrist showing adequate posi-
ioning of the dorsal AO compact plates.
n this rare condition and the pathogenesis remains unclear. Some
uthors suggest that MRH  is a paraneoplastic phenomenon driven
y tumour associated cytokine(s) or cytokine dysregulation2–4
hich is supported by its association with malignancy (28%)5,6 and
uto-immune disease (17%).6
MRH  affects women more commonly than men  (3:1), usu-
lly during the 4th decade of life and with no obvious ethnic
redilection. The disease usually remits spontaneously within
–10 years, but not before signiﬁcantly deforming multiple joints
nd potentially inﬁltrating the skin, skeletal muscle, heart, lungs
nd gastrointestinal tract. Usually, the polyarthritis symmetrically
ffects the small joints of the hand, but may  also involve the wrist
nd larger joints. MRH  is documented to be the most destructive
hronic inﬂammatory polyarthritis resulting in arthritis mutilans
n over 45% of cases.7
MRH  skin lesions are normally fast growing, non-tender and
ell-circumscribed violaceous papules of 1–10 mm.  They most fre-
uently arise over the dorsal aspects of the small joints of the hands,
ut may  also appear on the elbows, neck, face and pinnae.8 Occa-
ionally, papules coalesce at the eponychium giving a cobble stone
ppearance, known as ‘coral beading’. Sometimes, such lesions are
istaken for dermatomyositis9 or Rheumatoid nodules, especially
n the presence of deforming arthritis. Indeed, these conditions may
o-exist so caution is required and histology is usually helpful.
There  is no diagnostic serological test for MRH. Recognised bio-
hemical abnormalities include raised serum and tissue TFN-,10
11ypercholesterolaemia (∼50%) and elevated inﬂammatory mark-
rs; however, there is still no consensus on the exact cytokine
roﬁle.6 Histologically, the dermis is inﬁltrated with histiocytic
nd multinucleated giant cells (25–40 m),  usually exhibitingPEN  ACCESS
ry Case Reports 4 (2013) 744– 747
eosinophilic ground-glass cytoplasm. Their nuclei are vesicular,
with distinct membranes and 1 or 2 prominent nucleoli. Such giant
cells are agreed to be PAS positive and diastase-resistant but S100
protein, CD1a and alpha-1-antitrypsin negative. Tissue surround-
ing the typical skin lesions shows diffuse lymphocytic inﬁltration
and appears ﬁbrotic with subtle loss and fragmentation of the
collagen matrix. A comprehensive description of the histological
features is offered by Gorman et al.6
There is no consensus on the management of MRH. Case-
based evidence to-date suggests that mild to moderate joint
disease may  be initially treated with glucocorticoids and immuno-
suppressive agents.12 Anti-TNF therapies have been largely
unsuccessful.10,13–17 Similarly bisphosphonate infusions have
shown no true beneﬁt,2–4,18 despite being known to accumulate in
the reticuloendothelial system inducing macrophages/monocytes
apoptosis and exerting anti-arthritic effects through the suppres-
sion of osteoclasts.19 Commonly, medical therapies follow a long
and protracted course with disappointing results. Also, due to
publication bias and other factors, it may  be assumed that the pro-
portion of non-responders is under-represented in the literature.
Of note, no reports to-date have suggested that physiotherapy or
splinting has a role in managing this ankylosing disease.
There are no published reports of surgical interventions for
MRH. Whilst inﬂammatory MCPJ arthritis may be amenable to
joint replacement or resurfacing, the pre-requisites of good bone
stock, minimal deformity and adequate supporting soft tissue20 are
almost always lacking in MRH. Also, in the absence of surgical liter-
ature on MRH  alongside insufﬁcient data on joint replacements for
well recognised small joint arthritis of the hand, we felt that offering
an athroplasty would not be ideal and a more predictable, deﬁnitive
procedure (in the form of arthrodesis) was appropriate. Therefore,
as with other mutilating arthritides, we  suggest that MRH  arthritis
refractory to medical therapy may  be addressed safely and satis-
factorily with arthrodesis of the MCPJs, PIPJs or DIPJs in accordance
with surgical options and patient preference. Once medical ther-
apies have been exhausted, we advise that clinicians collaborate
with Hand Surgeons in order to report on their experiences of
managing MRH  and elucidate the ideal treatment pathway.
3.  Conclusion
This is the ﬁrst report of hand surgery for MRH  and represents
a novel avenue of therapy. Although this report does not offer a
deﬁnitive management algorithm, we  advocate that clinicians seek
the input of Hand Surgeons in managing the inevitable and muti-
lating joint disease of this rare condition.
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